Clinical Trial Update: Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer [Phase 1]

View source ↗

Summary

This clinical trial is evaluating ribociclib given concurrently with postoperative radiation therapy in patients with high-risk HR+/HER2- breast cancer; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Ribociclib (ribociclib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Breast Cancer | Phase 1 | Status: RECRUITING